BookJeffrey Medin, Daniel Fowler, editors.
Contents:
T cell therapy: state-of-the-art
Extending the use of adoptive T cell immunotherapy for infections and cancer
Non-T cell therapeutic approaches
B lymphocytes in cancer immunology
Monoclonal antibody therapy for cancer
Natural killer cells for cancer immunotherapy
Dendritic cell-based cancer vaccines: practical considerations
Mesenchymal stromal cells: an emerging cell-based pharmaceutical
T cell therapeutic approaches
Tumor-specific mutations as targets for cancer immunotherapy
Counteracting subversion of MHC class II antigen presentation by tumors
Mechanisms and implications of immunodominance in CD8⁺ T-cell responses
T regulatory cells and cancer immunotherapy
Negative regulators in cancer immunology and immunotherapy
Genetically engineered antigen specificity in T cells for adoptive immunotherapy
Non-cellular aspects of cancer immunotherapy
Cytokine immunotherapy
Transcriptional modulation using histone deacetylase inhibitors for cancer immunotherapy
Combining cancer vaccines with conventional therapies
Combining oncolytic viruses with cancer immunotherapy
Radiation therapy and cancer treatment: from the basics to combination therapies that ignite immunity
Assessing immunotherapy through cellular and molecular imaging
Transplantation
Allogeneic and autologous transplantation therapy of cancer: converging themes.